Comorbid major depressive disorder in schizophrenia: a systematic review and meta-analysis

D Etchecopar-Etchart, T Korchia… - Schizophrenia …, 2021 - academic.oup.com
Comorbid major depressive disorder (MDD) in schizophrenia (SZ; SZ-MDD) has been
identified as a major prognostic factor. However, the prevalence and associated factors of …

Therapeutic targeting of α7 nicotinic acetylcholine receptors

RL Papke, NA Horenstein - Pharmacological Reviews, 2021 - ASPET
The α 7-type nicotinic acetylcholine receptor is one of the most unique and interesting of all
the members of the cys-loop superfamily of ligand-gated ion channels. Since it was first …

Smoking in schizophrenia: recent findings about an old problem

M Sagud, AM Peles, N Pivac - Current opinion in psychiatry, 2019 - journals.lww.com
Cigarette smoking continues to adversely affect the health of individuals with schizophrenia.
Both smoking and heavy nicotine dependence, given the complex biological findings, might …

Sexual dysfunctions in schizophrenia: Beyond antipsychotics. A systematic review

M Dumontaud, T Korchia, J Khouani, C Lançon… - Progress in Neuro …, 2020 - Elsevier
Background Sexual dysfunctions (SD) in schizophrenia are frequent with strong impact on
adherence and quality of life. Current recommendations stipulate to switch to prolactin …

Smoking in schizophrenia: an updated review

M Šagud, B Vuksan-Ćusa, N Jakšić… - Psychiatria …, 2018 - hrcak.srce.hr
Sažetak Patients with schizophrenia continue to have the highest rate of both smoking and
heavy nicotine dependence. The interaction between smoking and schizophrenia is …

Psychotic, mood, and anxiety disorders and venous thromboembolism: a systematic review and meta-analysis

C Kowal, H Peyre, A Amad, A Pelissolo… - Psychosomatic …, 2020 - journals.lww.com
Objective Several studies have shown that psychiatric disorders can be associated with
venous thromboembolism (VTE) risk, that is, pulmonary embolism (PE) and/or deep vein …

Oral health in schizophrenia patients: a French multicenter cross-sectional study

F Denis, G Milleret, T Wallenhorst, M Carpentier… - La Presse Médicale, 2019 - Elsevier
Objective The aim of this study was to assess the oral health status of a sample of patients
with schizophrenia (PWS) in Côte d'Or region (France) and to determine the factors …

Tobacco use in first-episode psychosis, a multinational EU-GEI study

T Sanchez-Gutierrez, E Rodríguez-Toscano… - Psychological …, 2023 - cambridge.org
BackgroundTobacco is a highly prevalent substance of abuse in patients with psychosis.
Previous studies have reported an association between tobacco use and schizophrenia …

Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national …

J Mallet, Y Le Strat, F Schürhoff, N Mazer… - European archives of …, 2019 - Springer
Tobacco smoking is common in schizophrenia and is one of the main causes of premature
mortality in this disorder. Little is known about clinical correlates and treatments associated …

Machine learning for predicting psychotic relapse at 2 years in schizophrenia in the national FACE-SZ cohort

G Fond, E Bulzacka, M Boucekine, F Schürhoff… - Progress in Neuro …, 2019 - Elsevier
Background Predicting psychotic relapse is one of the major challenges in the daily care of
schizophrenia. Objectives To determine the predictors of psychotic relapse and follow-up …